DASATINIB (SPRYCEL) AND ERLOTINIB (TARCEVA) FOR PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE 1 TRIAL

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Desjardins, A; Peters, KB; Vredenburgh, JJ; Friedman, HS; Reardon, DA

Published Date

  • November 1, 2010

Published In

Volume / Issue

  • 12 /

Start / End Page

  • 51 - 51

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference

Conference Location

  • Hollywood, FL

Conference Start Date

  • December 9, 2010

Conference End Date

  • December 12, 2010